Clinical Trial Update: CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates CMP-001 in combination with pre-operative SBRT for early-stage triple-negative breast cancer and is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CMP-001

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING